Evidence map›Paper›PMID 17689924›Full record

ArticleCellular signalling2007

Lysophosphatidic acid modulates c-Met redistribution and hepatocyte growth factor/c-Met signaling in human bronchial epithelial cells through PKC delta and E-cadherin.

Yutong Zhao, Donghong He, Randi Stern, Peter V Usatyuk, Ernst Wm Spannhake, Ravi Salgia, Viswanathan Natarajan

Open access · greenAbstract read
In one paragraph

Article in Cellular signalling, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yutong ZhaoDepartment of Medicine, University of Chicago, Chicago, IL 60637, USA. yzhao@medicine.bsd.uchicago.edu
Donghong He
Randi Stern
Peter V Usatyuk
Ernst Wm Spannhake
Ravi Salgia
Viswanathan Natarajan
University of Chicago · USJohns Hopkins University · US

Funding

Role of c-Met in SCLC and Potential for Novel TherapyR01CA100750 · NCI · UNIVERSITY OF CHICAGO · PI SALGIA, RAVI · 2004 to 2012
$2.2M
Intracellular S1P &signaling in lung endothelial cellsR01HL079396 · NHLBI · UNIVERSITY OF CHICAGO · PI NATARAJAN, VISWANATHAN · 2005 to 2009
$1.8M
Lung Epithelial Inflammation by Lysophosphatidic AcidR01HL071152 · NHLBI · UNIVERSITY OF CHICAGO · PI NATARAJAN, VISWANATHAN · 2002 to 2005
$1.6M
Protective Role of Intracellular S1P in Lung InjuryR37HL079396 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NATARAJAN, VISWANATHAN · 2010 to 2010
$393k
NCI NIH HHS CA100750NCI NIH HHS CA109640NCI NIH HHS R01 CA100750NHLBI NIH HHS HL71152NHLBI NIH HHS HL79396NHLBI NIH HHS R01 HL071152NHLBI NIH HHS R01 HL079396NHLBI NIH HHS R37 HL079396
6 · The paper itself

Abstract

Previously we demonstrated that ligation of lysophosphatidic acid (LPA) to G protein-coupled LPA receptors induces transactivation of receptor tyrosine kinases (RTKs), such as platelet-derived growth factor receptor beta (PDGF-Rbeta) and epidermal growth factor receptor (EGF-R), in primary cultures of human bronchial epithelial cells (HBEpCs). Here we examined the role of LPA on c-Met redistribution and modulation of hepatocyte growth factor (HGF)/c-Met pathways in HBEpCs. Treatment of HBEpCs with LPA-induced c-Met serine phosphorylation and redistribution to plasma membrane, while treatment with HGF-induced c-Met internalization. Pretreatment with LPA reversed HGF-induced c-Met internalization. Overexpression of dominant negative (Dn)-PKC delta or pretreatment with Rottlerin or Pertussis toxin (PTx) attenuated LPA-induced c-Met serine phosphorylation and redistribution. Co-immnuoprecipitation and immunocytochemistry showed that E-cadherin interacted with c-Met in HBEpCs. LPA treatment induced E-cadherin and c-Met complex redistribution to plasma membranes. Overexpression of Dn-PKC delta attenuated LPA-induced E-cadherin redistribution and E-cadherin siRNA attenuated LPA-induced c-Met redistribution to plasma membrane. Furthermore, pretreatment of LPA attenuated HGF-induced c-Met tyrosine phosphorylation and downstream signaling, such as Akt kinase phosphorylation and cell motility. These results demonstrate that LPA regulates c-Met function through PKC delta and E-cadherin in HBEpCs, suggesting an alternate function of the cross-talk between G-protein-coupled receptors (GPCRs) and RTKs in HBEpCs.

Indexed as

AcetophenonesBenzopyransBronchiCadherinsCell MovementCells, CulturedEndocytosisEpithelial CellsGTP-Binding Protein alpha Subunits, Gi-GoHepatocyte Growth FactorHumansLysophospholipidsModels, BiologicalPhosphoserinePhosphotyrosineProtein BindingAcetophenonesBenzopyransCadherinsGTP-Binding Protein alpha Subunits, Gi-GoHepatocyte Growth Factorlysophosphatidic acidLysophospholipidsPhosphoserinePhosphotyrosineProtein Kinase C-deltaProto-Oncogene Proteins c-metRNA, Small Interferingrottlerin

Identifiers

PMID17689924
PMCPMC2149844
OpenAlexW2056411049

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.